Limited quantity of antiviral Remdesivir available in Puerto Rico
Quantity supplied to island is for 36 patients
SAN JUAN – The secretary of the Puerto Rico Department of Health, Lorenzo González Feliciano, announced that the antiviral drug Remdesivir is now available and arrived in Puerto Rico, after receiving confirmation from the U.S. Health Department that it would be delivered to states and territories.
“This week we, were informed that the federal Health Department authorized the release of the Remdesivir medication to the territories. Said medication arrived in Puerto Rico last Tuesday, on a limited basis; however, it is the first step for its distribution on the island. We are confident that we can receive additional doses to serve a greater number of patients,” González Feliciano explained in a statement.
He explained that the quantity supplied to the island is for 36 patients, so, for the moment, its distribution is limited.
“The Division of Medicines and Pharmacy of SARAFS [Spanish acronym for Auxiliary Secretariat for the Regulation and Accreditation of Health Facilities] developed an application form for hospital facilities that require it. The document establishes the criteria for using the drug Remdesivir to guarantee patient safety, based on the recommendations of the FDA [Food and Drug Administration] and the manufacturer,” he added.
The Health secretary added that “we are in the final process of reviewing the procedure and the required documentation, to have the endorsement of the Hospital Association and the associations of Infectologists and Pneumologists of Puerto Rico and thus begin their distribution. We want to guarantee that the use of said medicine serves patients who need it, under the highest health standards.”
The treatment will be administered to patients who require it in hospital facilities under the supervision of the aforementioned specialists and will have no cost to patients.